In Veritas Medical Diagnostics, Inc.
IVME · OTC
7/31/2021 | 7/31/2007 | 7/31/2006 | 7/31/2005 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | – | -100% | 44.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | – | – | 100% | 99.5% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $2 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $3 | $2 | $3 |
| Operating Income | -$0 | $3 | $1 | $2 |
| % Margin | – | – | 75.4% | 257.5% |
| Other Income/Exp. Net | $0 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$0 | -$4 | -$2 | -$2 |
| Tax Expense | $0 | -$5 | $1 | $0 |
| Net Income | -$0 | -$4 | -$2 | -$2 |
| % Margin | – | – | -145.4% | -278.5% |
| EPS | -0.001 | -0.062 | -0.034 | -0.047 |
| % Growth | 97.9% | -84.8% | 27.9% | – |
| EPS Diluted | -0.002 | -0.062 | -0.034 | -0.047 |
| Weighted Avg Shares Out | 60 | 59 | 55 | 53 |
| Weighted Avg Shares Out Dil | 60 | 59 | 55 | 53 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$3 | -$1 | -$2 |
| % Margin | – | – | -77.4% | -254.4% |